BNY Mellon Select Managers Small Cap Value Fund HAE Holdings History
BNY Mellon Select Managers Small Cap Value Fund's Haemonetics Corp Holding Summary
As of 2024-05-31, BNY Mellon Strategic Funds, Inc. held - shares of Haemonetics Corp(HAE), totaling N/A. This investment constitutes 0% of their stock portfolio, and BNY Mellon Strategic Funds, Inc. now holds 0% of the outstanding Haemonetics Corp(HAE) stock.
The initial trade took place in 2019Q4. And since then BNY Mellon Select Managers Small Cap Value Fund has made 2 purchases of HAE, at an average price of $76.92, for a total of 97,163.00 shares. In addition, there have been 11 sales at an average price of $78.69 for 97,163.00 shares. Based on historical transaction data and HAE's current price of $74.83, BNY Mellon Select Managers Small Cap Value Fund's estimated gain on his HAE holdings is $172,504.93, reflecting a 2.31% gain to date.
BNY Mellon Select Managers Small Cap Value Fund HAE ($74.83) Holding Chart
BNY Mellon Select Managers Small Cap Value Fund HAE ($74.83) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
